A Wheat-Based Enzyme
A drug for celiacia – a gluten sensitive enteropathy – has been developed by reseachers at the First MSMU named after I.M. Sechenov.
Employees of the Institute of Molecular Medicine at the First MSMU isolated an enzyme (triticain alpha) from wheat, capable of splitting gluten protein to easily digested peptides. Having obtained triticain alpha by biotechnological methods and having obtained the patent for the new development, the researchers have now developed a capsule-based drug for oral use before meal.
Preclinical studies of the new drug are ongoing.
If all studies are successfully completed, the new drug will make life more simple for at least 1% of the global population suffering from celiacia, who have to keep to gluten free diet.